Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Global PD-1 and PD-L1 Inhibitors Market Outlook

The global PD-1 and PD-L1 inhibitors market size was valued at USD 45.8 billion in 2024, driven by increasing incidence of cancer cases across the globe. The market is expected to grow at a CAGR of 17.96% during the forecast period of 2025-2034, with the values likely to attain USD 202.5 billion by 2034.

PD-1 and PD-L1 Inhibitors: Introduction

PD-1 and PD-L1 inhibitors are checkpoint inhibitors used to block the activity of PD-1 and PDL1 immune checkpoint proteins, commonly present on the surface of cells. These inhibitors play a pivotal role in offering immunotherapy to cancer patients. The interaction of these cell surface proteins is also engaged in the immune system suppression and occurs following infection to restrain the killing of bystander host cells and avoid autoimmune disease.

Global PD-1 and PD-L1 Inhibitors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global PD-1 and PD-L1 Inhibitors Market Analysis

The growing incidence of cancer has propelled deeper research into various types of therapies that could be found useful in offering treatment alternatives to patients. There is heightened focus on immunotherapy, owing to the rising requirements of personalized medicine in patients. Consequently, the PD-1 and PD-L1 inhibitors market demand has seen significant upswing in recent years.

Over the years, PD-1 inhibiotrs like Pembrolizumab (Keytruda), Nivolumab (Opdivo), Cemiplimab (Libtayo) and PD-L1 inhibitors Atezolizumab (Tecentriq), Avelumab (Bavencio) and Durvalumab (Imfinzi) have been the most used inhibitors in the market. However, with a better understanding the human physiology and increased technical advancements, innovations keep emerging in the market. For instance, in March 2023, the FDA approved Incyte’s intravenous drug, Zynyz, which can be used to treat metastatic or recurrent locally advanced Merkel cell carcinoma (MCC).

In addition, new technologies have been introduced to improve the quality and efficacy of drugs further. In November 2023, a liquid biopsy company called Angle that offers circulating tumour cell diagnostic solutions launched its Portrait PD-L1 test. This test works to evaluate the protein expression of PD-L1 on CTCs. Therefore, the PD-1 and PD-L1 inhibitors market value is anticipated to grow further during the forecast period.

Global PD-1 and PD-L1 Inhibitors Market Segmentation

Global PD-1 and PD-L1 Inhibitors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Type

  • PD-1 Inhibitors
  • PD-L1 Inhibitors

Market Breakup by Application

  • Hodgkin Lymphoma
  • Kidney Cancer
  • Melanoma
  • Non-Small Cell Lung Cancer
  • Other Applications

Market Breakup by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global PD-1 and PD-L1 Inhibitors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global PD-1 and PD-L1 Inhibitors Market Overview

In the forecast period, North America is predicted to possess a significant PD-1 and PD-L1 inhibitors market share. This can be attributed to the rising technical advancements and the existence of a well-equipped healthcare infrastructure to integrate the new age advancements. The presence of prominent MedTech companies and research institutions is another major factor driving the market. Similarly, Europe with a robust healthcare ecosystem is a significant player in the market. The region also focuses on educating and training the medical staff to function well with all the rising innovation.

The Asia Pacific region, on the other hand, is projected to witness rapid PD-1 and PD-L1 inhibitors market growth. Given the increasing adoption of new technologies to improve the medical ecosystem and foster innovation, the region is continuously growing and developing for better patient care. The presence of an aging population is driving development. In addition, there is a significant influx of international investments, with several key healthcare players setting up new and high-end research labs in the region to leverage the academic talent available.

Global PD-1 and PD-L1 Inhibitors Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Bristol Myers Squibb
  • Merck & Co., Inc.
  • Roche
  • AstraZeneca
  • Pfizer, Inc.
  • Eli Lilly and Company
  • Sanofi
  • Regeneron Pharmaceuticals
  • Novartis AG
  • BIOCAD
  • Cipla Limited
  • MacroGenics, Inc.
  • Innovent Biologics
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Mirati Therapeutics

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Applications
  • Distribution Channel
  • Region
Breakup by Type
  • PD-1 Inhibitors
  • PD-L1 Inhibitors
Breakup by Applications
  • Hodgkin’s Lymphoma
  • Kidney Cancer
  • Melanoma
  • Non-Small Cell Lung Cancer
  • Other Applications
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Bristol Myers Squibb
  • Merck & Co., Inc.
  • Roche
  • AstraZeneca
  • Pfizer, Inc.
  • Eli Lilly and Company
  • Sanofi
  • Regeneron Pharmaceuticals
  • Novartis AG
  • BIOCAD
  • Cipla Limited
  • MacroGenics, Inc.
  • Innovent Biologics
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Mirati Therapeutics

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 45.8 billion in 2024, driven by rising prevalence of cancer cases across the globe.

The market is anticipated to grow at a CAGR of 17.96% during the forecast period of 2025-2034, likely to reach a market value of USD 202.5 billion by 2034.

The market demand is driven by increased demand for efficient cancer treatment solutions along with rising geriatric population and increased investments by the governments to support the healthcare and pharmaceutical industries.

The current market trend involves the advent of new drugs to treat rare cancer types. In March 2023, the FDA approved an intravenous drug called Zynyz, developed by Incyte which can be used to treat metastatic or recurrent locally advanced Merkel cell carcinoma (MCC).

The market can be divided into PD-1 and PD-L1 inhibitors.

These inhibitors find wide applications in Hodgkin lymphoma, kidney cancer, melanoma, and non-small cell lung cancer, among others.

Major distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Key players involved in the market are Bristol Myers Squibb, Merck & Co., Inc., Roche, AstraZeneca, Pfizer, Inc., Eli Lilly and Company, Sanofi, Regeneron Pharmaceuticals, Novartis AG, BIOCAD, Cipla Limited, MacroGenics, Inc., Innovent Biologics, Jiangsu Hengrui Medicine Co., Ltd. and Mirati Therapeutics.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Selected Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Selected Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124